Testing effectiveness (Phase 2)Ended earlyNCT00857259
What this trial is testing
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Who this might be right for
Choroidal Neo-Vascular Age-onset Macular DegenerationAge-related Macular Degeneration
Novartis Pharmaceuticals 16